The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of the contemporary use of high-dose chemotherapy (HDCT) in germ cell tumors (GCT) in Europe: Early findings of an ongoing EBMT-sponsored study.
Andrea Necchi
No relevant relationships to disclose
Manuela Badoglio
No relevant relationships to disclose
Rosalba Miceli
No relevant relationships to disclose
Jean-Henri Bourhis
No relevant relationships to disclose
Daniele Laszlo
No relevant relationships to disclose
Emmanuelle Nicolas-Virelizier
No relevant relationships to disclose
Patrick Wuchter
No relevant relationships to disclose
Peter Dreger
No relevant relationships to disclose
William Hermann Kruger
No relevant relationships to disclose
Ali Unal
No relevant relationships to disclose
Antonio Campos
No relevant relationships to disclose
Juan Montoro
No relevant relationships to disclose
Daniele Raggi
No relevant relationships to disclose
Patrizia Giannatempo
No relevant relationships to disclose
Alessandro M. Gianni
No relevant relationships to disclose
Paolo Pedrazzoli
No relevant relationships to disclose
Francesco Lanza
No relevant relationships to disclose